Insulin aspart, recombinant Subcutaneous and Stelara (Ustekinumab Intravenous Infusion)
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Stelara (Ustekinumab Intravenous Infusion) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: ustekinumab
Brand name: Stelara, Stelara PFS
Synonyms: Stelara
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Stelara (Ustekinumab Subcutaneous Injection)
- Insulin aspart, recombinant Subcutaneous-Stelazine
- Insulin aspart, recombinant Subcutaneous-Stemetic
- Insulin aspart, recombinant Subcutaneous-Stemetil
- Insulin aspart, recombinant Subcutaneous-Stendra
- Insulin aspart, recombinant Subcutaneous-Sterapred
- Stelara (Ustekinumab Intravenous Infusion)-Insulin degludec
- Stelara (Ustekinumab Intravenous Infusion)-Insulin Degludec (U-100) Prefilled Pens
- Stelara (Ustekinumab Intravenous Infusion)-Insulin Degludec (U-100) Vials
- Stelara (Ustekinumab Intravenous Infusion)-Insulin Degludec (U-200) Prefilled Pens
- Stelara (Ustekinumab Intravenous Infusion)-Insulin degludec and liraglutide
- Stelara (Ustekinumab Intravenous Infusion)-Insulin degludec and liraglutide Subcutaneous